Fund HoldingsAtlas Venture Life Science Advisors, LLC

Total Portfolio Value
$645.63M
Total Bought
$3.24M
Total Sold
$37.18M
Net Transaction
-$33.94M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
Third Harmonic Bio, Inc.10,907,85910,907,859052,46769,70110.80%+17,234
Dianthus Therapeutics, Inc.(DNTH)0236,979+236,97903,2400.50%+3,240
AvroBio, Inc.4,541,3814,541,38104,3156,9941.08%+2,679
Day One Biopharmaceuticals, Inc.
COM
7,608,3947,608,394090,84493,35514.46%+2,511
Spero Therapeutics, Inc.1,013,4381,013,43801,4691,2260.19%-243
Xilio Therapeutics, Inc.2,759,3442,759,34407,2295,8220.90%-1,407
Magenta Therapeutics, Inc.3,791,6980-3,791,6982,8740-2,874
Aerovate Therapeutics, Inc.2,039,2492,039,249034,97327,6734.29%-7,301
Akero Therapeutics, Inc.594,251359,251-235,00027,74618,1712.81%-9,575
Ikena Oncology, Inc.5,018,1785,018,178032,91921,7293.37%-11,191
Replimune Group, Inc.(REPL)2,098,3002,098,300048,72335,9025.56%-12,821
Generation Bio, Co.8,279,4848,279,484045,53731,3794.86%-14,158
Dyne Therapeutics, Inc.(DYN)9,885,4499,885,4490111,21188,57413.72%-22,638
Vigil Neuroscience, Inc.5,836,8745,836,874054,86731,4614.87%-23,406
Disc Medicine, Inc.(IRON)3,461,7842,745,335-716,449153,703128,97619.98%-24,727
Kymera Therapeutics, Inc.(KYMR)5,858,2625,858,2620134,68181,43012.61%-53,252
Page 1 of 1